BMY

Bristol Myers Squibb
$62.56
+$0.47 (+0.76%)Jul 27, 2026
9.3GreatMoatMint rating

MoatMint rates Bristol Myers Squibb (BMY) 9.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 9.5 out of 10.

Key metrics

The numbers that frame BMY today
Market cap
$127.75B
P/E (TTM)
17.6
EV / FCF
13.7
Gross margin
70.5%
EV / Sales
3.4
ROIC
15.8%
Div yield
4%
Debt / equity
2.2
52wk Low
$41.01
52wk High
$63.44

BMY stock rating

How BMY scores on quality, value, growth, momentum and financial health
9.3out of 10
Great overallHealthy business, attractive priceTop 7% of ~5,000 US stocks
QualityGreat9.5/10
GrowthNeutral4.0/10
MomentumGood6.4/10
ValueGreat8.5/10
Financial HealthGreat8.5/10

Growth

Revenue and earnings trend for BMY
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about BMY
Is Bristol Myers Squibb a good buy?
Yes. Bristol Myers Squibb has excellent quality and strong momentum. Both signals support the setup. Growth looks weak, a caveat that does not overturn the setup. We think Bristol Myers Squibb is selling at a low price.
What is the market capitalization of BMY?
Bristol Myers Squibb's market capitalization is $127.75B.
What is the P/E ratio for BMY stock?
Bristol Myers Squibb's current P/E ratio is 17.6.
What is the 52-week high for BMY stock?
The 52-week high for Bristol Myers Squibb is $63.44. The current close of $62.56 is 1.4% below that high.
What is the 52-week low for BMY stock?
The 52-week low for Bristol Myers Squibb is $41.01. The current close of $62.56 is 52.6% above that low.
Does BMY stock pay dividends?
Bristol Myers Squibb pays a dividend. The latest dividend per share in the company data is $2.50, which implies a yield of 4.00% based on the current close.
What is the Debt / Equity ratio for BMY?
Bristol Myers Squibb's Debt / Equity ratio is 2.22.